Silo Pharma (Nasdaq: SILO) announced it has engaged drug-device development partner Resyca to conduct a robustness study on the microchip-based ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE